Overview
- Elon Musk said on X that Neuralink will begin high‑volume manufacturing this year and shift to an almost entirely automated implantation process.
- Musk said the new procedure will thread electrodes through the dura without removing it, describing the approach as a significant technical advance.
- Neuralink reports a next‑generation surgical robot designed for faster, deeper thread insertion to support scalable, lower‑cost procedures.
- By September 2025 the company said 12 people with severe paralysis had received implants and were actively controlling digital tools, with early users demonstrating cursor control, gaming, browsing, and social posting.
- Neuralink previously gained FDA clearance to begin human trials in 2024 and later received approval for a speech‑restoration indication, alongside a $650 million Series E that valued the company at about $9 billion.